Global Biotech Ingredient Market
Pharmaceuticals

Biotech Ingredient Market Growth Outlook Reveals A CAGR Of 6.6% And A Market Value Of $87.05 Billion By 2030

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Biotech Ingredient Market Size Forecast: How Large Could The Market Become By 2030?

The biotech ingredient sector has seen robust expansion over recent years, with projections showing an increase from $63.25 billion in 2025 to $67.42 billion in 2026—representing a compound annual growth rate (CAGR) of 6.6%. This historical growth has been driven by a rising need for natural and safe components, progress in microbial fermentation methods, heightened understanding of biotechnology’s role in food and personal care products, a growing consumer shift toward sustainable options, and the initial uptake of compounds derived from yeast and algae.

The biotech ingredient market is anticipated to experience robust expansion over the coming years, with projections indicating a rise to $87.06 billion by 2030 at a compound annual growth rate of 6.6%. This forecasted growth is driven by factors such as the widening scope of precision medicine and personalized nutrition, enhanced governmental backing for biotech research and development, the upscaling of microbial and yeast expression systems, the integration of artificial intelligence and automation into manufacturing processes, and an increasing range of uses in sectors like cosmetics, cleaning products, and food. Key trends influencing this period include progress in synthetic biology, breakthroughs in microbial engineering, more cost-efficient methods for producing ingredients, a stronger focus on regulatory compliance and safety protocols, and a broader adoption within the food, personal care, and cleaning industries.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Biotech Ingredient Market Growth Momentum: Which Factors Are Influencing Demand?

The biotech ingredient market is set to expand further, fueled by an escalating demand for personal care products. These products encompass a wide array of items designed to uphold personal hygiene and improve appearance. The incorporation of biotech ingredients into such products provides numerous advantages, including a smaller environmental footprint, sustainability, dependable uniformity, decreased allergenic potential, biocompatibility, better efficacy, and a lower reliance on petrochemicals. As an illustration, the Bureau of Labor Statistics, a US governmental agency, reported in December 2024 that the typical yearly expenditure on personal care items and services increased from $866 per consumer unit in 2022 to $950 per consumer unit in 2023. Consequently, the rising need for personal care items is propelling the expansion of the biotech ingredient market.

Biotech Ingredient Market Segment Outlook: Which Categories Are Expanding The Fastest?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

Biotech Ingredient Market Trends Reshaping Industry Growth

Key industry players within the biotech ingredient space are concentrating on the creation of advanced solutions, such as cutting-edge platforms built on biotechnology, to address the growing need for high-performance, sustainable, and next-generation formulas in cosmetics and personal care. These biotechnology-derived components employ enzymatic and bio-based methods to generate unique molecular architectures with improved capabilities, delivering superior functionality, scalability, and ecological advantages over conventional chemically produced alternatives. In March 2023, International Flavors & Fragrances Inc., an American producer of fragrances, biotech innovations, cosmetic actives, and organic health ingredients, released Aurist AGC, a novel biopolymer intended for hair care applications. This demonstrates the potential of the new DEB platform by harnessing IFF’s complete biotechnological capabilities to deliver enduring, high-performance glamour solutions that can genuinely drive transformation within the cosmeceutical sector. This ingredient utilizes IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnological method capable of creating new bio-based polysaccharides featuring unique structures and product attributes.

Biotech Ingredient Market Key Companies And Competitive Benchmarking

Major companies operating in the biotech ingredient market are Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Access The Complete Biotech Ingredient Market Report:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Biotech Ingredient Market Largest Region By Revenue And Market Share

Europe was the largest region in the biotech ingredient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model